Researchers assessed chromatin patterns in pediatric acute lymphoblastic leukemia patients with the histone 3 lysine 36 dimethylation signature and found a mutation in the methyltransferase enzyme-coding gene called NSD2. The findings, published in the journal Nature Genetics, suggest that chromatin profiling is a promising tool for detecting genetic mutations with unknown epigenetic consequences.

Related Summaries